U.S. Entertainment Stock News

CNA Financial Corporation has already reported first-quarter 2026 results, with revenue of US$3,677 million and net income of US$211 million, as weaker underwriting and unfavorable reserve development weighed on earnings per share of US$0.78. Despite the softer profitability and a higher combined ratio in its Property & Casualty business, the board maintained a regular quarterly dividend of US$0.48 per share, signaling continued confidence in the company’s capital position. We’ll now...

Omnicom Group stock snapshot Omnicom Group (OMC) has recently drawn investor attention after a period of mixed share performance, with the stock showing a month gain alongside a negative year to date return and modest 1 year total return. At a recent close of US$76.27, Omnicom Group sits against a backdrop of global operations in advertising, marketing, and corporate communications, serving clients across North America, Europe, the Asia Pacific, Latin America, and the Middle East and...

Revolution Medicines (RVMD) is back in focus after the FDA cleared expanded access to its investigational drug daraxonrasib for certain metastatic pancreatic cancer patients, following Phase 3 data showing improvements in overall survival and progression-free survival. See our latest analysis for Revolution Medicines. The stock’s recent move appears closely linked to the daraxonrasib news flow, with a 1 day share price return of 6.04% and a 30 day share price return of 49.21% contributing to...

Old National Bancorp (ONB) drew investor attention after reporting first quarter net interest income of US$572.57 million and net income of US$233.67 million, along with US$32 million in net charge offs and updated share repurchase activity. See our latest analysis for Old National Bancorp. The first quarter update, including higher reported net interest income and net income alongside US$32 million of net charge offs and recent buyback activity, comes as the share price sits at US$23.78 with...

In early May 2026, WEX Inc. and activist investor Impactive Capital reached a cooperation agreement that ended their proxy contest, added three Impactive-backed nominees to an expanded 11-member board, and committed WEX to separating its Chair and CEO roles after the upcoming annual meeting. This governance reset, arriving after months of public debate and proxy advisor scrutiny, signals a meaningful shift in how shareholder influence will shape WEX’s oversight and long-term decisions...

Earnings jump draws fresh focus to Equitable Holdings stock Equitable Holdings (EQH) just posted first quarter results that show net income of US$621 million compared with US$63 million a year earlier, while revenue for the quarter was US$4.23 billion versus US$4.58 billion. See our latest analysis for Equitable Holdings. At a share price of US$41.49, Equitable Holdings has a 30 day share price return of 9.79%, while its 1 year total shareholder return of 15.58% decline contrasts with an...

Capricor Therapeutics (CAPR) stock is in focus after the company presented Phase 3 HOPE 3 data for Deramiocel in Duchenne muscular dystrophy at the American Academy of Neurology 2026 Annual Meeting. See our latest analysis for Capricor Therapeutics. That update comes after a sharp move in Capricor Therapeutics stock, with a 1-day share price return of 8.38% and a 90-day share price return of 34.65%, alongside a very large 1-year total shareholder return that sits in the mid single digit...

Pediatrix Medical Group, Inc. has reported past first-quarter 2026 results showing sales of US$476.2 million and net income of US$29.57 million, with diluted earnings per share from continuing operations of US$0.36, all higher than the same period a year earlier. The company’s better-than-expected performance, driven by stronger same-unit revenue and improved cash collections, came alongside a reaffirmed full-year adjusted EBITDA outlook that supports management’s operational and financial...

Amylyx Pharmaceuticals stock in focus Amylyx Pharmaceuticals (AMLX) has drawn investor attention after recent trading, with the stock closing at US$16.46 and a market value of about US$1.78b, backed by a clinical stage pipeline in neurodegenerative and endocrine conditions. See our latest analysis for Amylyx Pharmaceuticals. The recent 2.81% 1 day share price return and 10.10% 30 day share price return sit alongside a 44.13% year to date share price return. The 1 year total shareholder return...

Moderna (MRNA) is back in focus after first quarter 2026 results, with revenue of US$389 million, a GAAP net loss of US$1.343b, new EU vaccine approvals, and progress in its oncology pipeline. See our latest analysis for Moderna. Moderna's share price has been volatile around the latest results, with a 1-day share price return of 4.25% but a 7-day return of 2.87%. A 90-day gain of 12.09% and year to date share price return of 53.27% contrast with a 3-year total shareholder return of 64.10%...

Q1 earnings and buyback completion put Mueller Industries in focus Mueller Industries (MLI) is back on investors’ radar after first quarter 2026 results showed higher sales, net income, and earnings per share compared with a year earlier, alongside the completion of a long running share repurchase program. See our latest analysis for Mueller Industries. The earnings beat and completion of a long running buyback have come after a 1 month share price return of 18.18% and a 1 year total...

Patrick Industries stock performance snapshot Patrick Industries (PATK) has drawn investor attention after recent trading left the stock at US$85.13, with returns of about 4% over the past year and a little more than 100% over the past 3 years. See our latest analysis for Patrick Industries. Despite the recent pullback, with a 30 day share price return of a 26% decline and a 90 day share price return of a 36% decline, Patrick Industries still shows longer term momentum through a 3 year total...

Mueller Industries, Inc. ( NYSE:MLI ) announced strong profits, but the stock was stagnant. Our analysis suggests that...

The market for United Parcel Service, Inc.'s ( NYSE:UPS ) shares didn't move much after it posted weak earnings...

Shareholders appeared unconcerned with Kimberly-Clark Corporation's ( NASDAQ:KMB ) lackluster earnings report last...

We note that the The Western Union Company ( NYSE:WU ) President of Europe, Giovanni Angelini, recently sold US$57k...

Molina Healthcare reported past first-quarter 2026 results with revenue of US$10.80 billion and net income of US$14 million, alongside new guidance calling for full-year 2026 GAAP net income of US$97 million and at least US$1.90 in diluted EPS. Soon after, a shareholder law firm began investigating alleged nondisclosure around medical cost trend assumptions and 2025 guidance, raising fresh questions about the reliability of Molina’s recent outlook. We’ll now examine how the shareholder...

Saia, Inc. reported past first‑quarter 2026 results with sales of US$806.23 million and net income of US$49.87 million, essentially flat year on year, while earnings per share held at US$1.86. Behind the headline figures, shipment growth in both new and legacy terminals and improved safety and claims metrics pointed to early benefits from Saia’s network expansion and technology spending despite higher employee costs and weather disruptions. We’ll now examine how Saia’s shipment growth in...

Recent earnings and market reaction Burlington Stores (BURL) recently reported quarterly results showing revenue of US$3.65b, up 11.3% year on year, and EBITDA ahead of estimates, while guidance for next quarter’s EPS came in below market expectations. The stock has risen about 5.3% since the release, suggesting investors are weighing the stronger recent performance against the more cautious profit outlook for the coming quarter. See our latest analysis for Burlington Stores. Despite the...

Ichor Holdings recently reported first-quarter 2026 results, with sales increasing to US$256.07 million from US$244.47 million a year earlier and net loss narrowing to US$2.47 million from US$4.56 million, while loss per share improved to US$0.07 from US$0.13. The company also exceeded analyst expectations for both revenue and earnings and outlined plans to lift gross margin to at least 15% and increase Ichor-branded content to 35% of systems by year-end through its Global Footprint...

OSI Systems (OSIS) is on investors’ radar after record fiscal Q3 results, a reported backlog of about US$1.9b, reaffirmed full year guidance, and a new homeland defense radar contract worth up to US$235 million. See our latest analysis for OSI Systems. The latest record Q3 results, guidance reaffirmation, and the new homeland defense radar contract appear to sit behind a 10.5% 3 month share price return and a stronger 1 year total shareholder return of 28.25%. This suggests momentum has been...

In early May 2026, IES Holdings, Inc. reported Q2 2026 results showing sales of US$974.28 million and net income of US$109.91 million, with both quarterly and six-month earnings per share from continuing operations higher than a year earlier. Beyond the headline growth, the company pointed to especially strong contributions from its Communications and Infrastructure Solutions segments and a sharply higher backlog, supported by the recent acquisition of Gulf Island Fabrication. Next, we’ll...

Palo Alto Networks (NasdaqGS:PANW) CEO Nikesh Arora has issued a public warning on rising AI driven cybersecurity risks. Arora highlighted that generative AI is speeding up the discovery of software vulnerabilities and could increase the impact of cyberattacks. He called for faster development of protections for AI agents and legacy systems as enterprises adopt generative AI tools. Palo Alto Networks, a large cybersecurity company listed on the NasdaqGS as PANW, focuses on network security,...

JPMorgan Chase (JPM) is back in focus after reporting Q1 2026 net income of US$16.5b, revenue of US$49.8b and diluted EPS of US$5.94, with results above consensus expectations. See our latest analysis for JPMorgan Chase. Despite Q1 2026 earnings beating expectations and a stream of fixed income offerings that reinforce its funding access, JPMorgan Chase’s short term share price momentum has cooled, with a 1 month share price return of 4.43%, a year to date share price return of 5.48%, and a 1...